Cargando…
Stem cell factor SALL4, a potential prognostic marker for myelodysplastic syndromes
BACKGROUND: Myelodysplastic syndromes (MDS) are a group of heterogeneous diseases with variable clinical course. Predicting disease progression is difficult due to lack of specific molecular marker(s). SALL4 plays important roles in normal hematopoiesis and leukemogenesis. SALL4 transgenic mice deve...
Autores principales: | Wang, Fei, Guo, Ye, Chen, Qian, Yang, Zhuo, Ning, Ning, Zhang, Yujuan, Xu, Yonggang, Xu, Xiaodong, Tong, Chunrong, Chai, Li, Cui, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856454/ https://www.ncbi.nlm.nih.gov/pubmed/24283704 http://dx.doi.org/10.1186/1756-8722-6-73 |
Ejemplares similares
-
Dissecting the cell of origin of aberrant SALL4 expression in myelodysplastic syndrome
por: Tatetsu, Hiro, et al.
Publicado: (2023) -
The next new target in leukemia: The embryonic stem cell gene SALL4
por: Wang, Fei, et al.
Publicado: (2014) -
Stemness factor Sall4 is required for DNA damage response in embryonic stem cells
por: Xiong, Jianhua, et al.
Publicado: (2015) -
Prognostic Markers of Myelodysplastic Syndromes
por: Veryaskina, Yuliya Andreevna, et al.
Publicado: (2020) -
Stem Cell Factor SALL4 Represses the Transcriptions of PTEN and SALL1 through an Epigenetic Repressor Complex
por: Lu, Jiayun, et al.
Publicado: (2009)